ATG:biosynthetics

ATG:biosynthetics is a private German synthetic biology and biotechnology company focused on gene synthesis, gene optimization, bioinformatics, and multi-gene or multi-peptide construct design. The company provides research-use products and outsourced services spanning synthetic genes, gene clusters, expression systems, peptide library construction, and computational sequence optimization. Its platform technologies include EvoMAG for in silico design and optimization of genes and gene clusters, and PepID for peptide library design and expression. ATG appears to operate primarily as a tools, platform, and contract R&D partner rather than as a clinical-stage therapeutics developer, while expressing interest in strategic collaborations in areas such as DNA- and protein-based vaccines and engineered biosynthetic pathways.